AI assistant
ZOONO GROUP LIMITED — Capital/Financing Update 2017
Nov 23, 2017
66124_rns_2017-11-23_a65455e6-dad2-48c5-9779-2c04ad6ebdb6.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Zoono Group Limited
ABN: 73 006 645 754 Level 12 225 George Street Sydney NSW 2000 T: +61 (2) 8042 8481 www.zoono.com
==> picture [58 x 59] intentionally omitted <==
24 November 2017 ASX RELEASE
RELEASE OF SECURITIES FROM ESCROW
In accordance with Listing Rule 3.10A, Zoono Group Limited (ASX:ZNO) advises that 28,333 fully paid ordinary shares are due to be released from escrow on 9 December 2017.
The resulting capital structure will be as follows:
| Fully Paid Ordinary Shares |
Number | % |
|---|---|---|
| Free Float | 60,328,578 | 37.01% |
| Escrowed Shares | 102,683,249 | 62.99% |
| Total Shares | 163,011,827 | 100.00% |
For further information please contact:
Elissa Hansen Company Secretary 0411 764 556
About Zoono:
Zoono specialises in the development, manufacture and global distribution of a suite of proven, long lasting and environmentally friendly antimicrobial solutions. It has developed products, including aerosol-based sprays, suited for skin care, surface sanitisers, treatment of acne and mould remediation. The products are based around the “Zoono Molecule”; a unique, antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mould. It has proven efficacy, longevity and, importantly, it does not leach. Zoono products are currently sold in many countries.